Gene expression patterns in brain cortex of three different animal models of depression

Genes, Brain and Behavior

Volumn 7, Issue 6, 2008, Pages 649-658

  Uriguen L ^a,b   Arteta, D ^a,c   Diez Alarcia R ^a,b   Ferrer Alcon M ^c   Diaz A ^b,d,e   Pazos, A ^b,d,e   Meana, J J ^a,b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c Progenika Biopharma SA   (Spain)

^d UNIVERSITY OF CANTABRIA   (Spain)

^e University of Cantabria   (Spain)

Author keywords

Animal models; Brain cortex; Depression; Gene expression; Microarrays; RT PCR

Indexed keywords

ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; COMPLEMENT COMPONENT C3; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 7; GROWTH FACTOR; MU 1 OPIATE RECEPTOR; MU OPIATE RECEPTOR; NEUROTROPHIC TYROSINE KINASE RECEPTOR TYPE 1; NEUROTROPHIC TYROSINE KINASE RECEPTOR TYPE 3; RESERPINE; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 1F RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN RECEPTOR; TACHYKININ RECEPTOR; TACHYKININ RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; MAJOR DEPRESSION; MALE; MICROARRAY ANALYSIS; NERVE CELL DIFFERENTIATION; NONHUMAN; OLFACTORY BULBECTOMY; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; VALIDATION STUDY;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN CHEMISTRY; CEREBRAL CORTEX; COMPLEMENT C3; CORTICOSTERONE; DENERVATION; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; FATTY ACID-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MALE; NERVE TISSUE PROTEINS; OLFACTORY BULB; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; RESERPINE; SPECIES SPECIFICITY;

ANIMALIA;

EID: 43749091358     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2008.00402.x     Document Type: Article

References (54)

1. Al-Shahrour, F., Diaz-Uriarte, R. Dopazo, J 2004) FatiGO: a web tool for finding significant associations of gene ontology terms with groups of genes. Bioinformatics 20, 578 580.
2. Arai, Y., Funatsu, N., Numayama-Tsuruta, K., Nomura, T., Nakamura, S. Osumi, N 2005) Role of Fabp7, a downstream gene of Pax6, in the maintenance of neuroepithelial cells during early embryonic development of the rat cortex. J Neurosci 25, 9752 9761.
3. Arborelius, L., Owens, M.J., Plotsky, P.M. Nemeroff, C.B 1999) The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 160, 1 12.
4. Barbany, G. Persson, H 1992) Regulation of neurotrophin mRNA expression in the rat brain by glucocorticoids. Eur J Neurosci 4, 396 403.
5. Bergstrom, A., Jayatissa, M.N., Thykjaer, T. Wiborg, O 2007) Molecular pathways associated with stress resilience and drug resistance in the chronic mild stress rat model of depression: a gene expression study. J Mol Neurosci 33, 201 215.
6. Bittel, D.C., Kibiryeva, N., McNulty, S.G., Driscoll, D.J., Butler, M.G. White, R.A 2007) Whole genome microarray analysis of gene expression in an imprinting center deletion mouse model of Prader-Willi syndrome. Am J Med Genet A 143, 422 429.
7. Cairncross, K.D., Cox, B., Kerwin, R., Forster, C. Wren, A.F 1978) Behavioural changes induced by olfactory bulb ablation and intrabulbar injection of 5,6-DHT: susceptibility to psychotropic drugs [proceedings]. Br J Pharmacol 62, 400P 401P.
8. Castren, E., Voikar, V. Rantamaki, T 2007) Role of neurotrophic factors in depression. Curr Opin Pharmacol 7, 18 21.
9. Chen, B., Dowlatshahi, D., MacQueen, G.M., Wang, J.F. Young, L.T 2001) Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50, 260 265.
10. Chourbaji, S. Gass, P 2008) Glucocorticoid receptor transgenic mice as models for depression. Brain Res Rev 57, 554 560.
11. Coppen, A 1967) The biochemistry of affective disorders. Br J Psychiatry 113, 1237 1264.
12. Cryan, J.F., Markou, A. Lucki, I 2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23, 238 245.
13. Czeh, B., Muller-Keuker, J.I., Rygula, R., Abumaria, N., Hiemke, C., Domenici, E. Fuchs, E 2007) Chronic social stress inhibits cell proliferation in the adult medial prefrontal cortex: hemispheric asymmetry and reversal by fluoxetine treatment. Neuropsychopharmacology 32, 1490 1503.
14. Dwivedi, Y., Mondal, A.C., Payappagoudar, G.V. Rizavi, H.S 2005) Differential regulation of serotonin (5HT)2A receptor mRNA and protein levels after single and repeated stress in rat brain: role in learned helplessness behavior. Neuropharmacology 48, 204 214.
15. El Yacoubi, M. Vaugeois, J.M 2007) Genetic rodent models of depression. Curr Opin Pharmacol 7, 3 7.
16. Evans, S.J., Choudary, P.V., Neal, C.R., Li, J.Z., Vawter, M.P., Tomita, H., Lopez, J.F., Thompson, R.C., Meng, F., Stead, J.D., Walsh, D.M., Myers, R.M., Bunney, W.E., Watson, S.J., Jones, E.G. Akil, H 2004) Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci U S A 101, 15506 15511.
17. Faure, J., Uys, J.D., Marais, L., Stein, D.J. Daniels, W.M 2006) Early maternal separation followed by later stressors leads to dysregulation of the HPA-axis and increases in hippocampal NGF and NT-3 levels in a rat model. Metab Brain Dis 21, 181 188.
18. Gibbons, J.L 1964) Cortisol secretion rate in depressive illness. Arch Gen Psychiatry 10, 572 575.
19. Gourley, S.L., Wu, F.J., Kiraly, D.D., Ploski, J.E., Kedves, A.T., Duman, R.S. Taylor, J.R 2008) Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression. Biol Psychiatry 63, 353 359.
20. Irizarry, R.A., Bolstad, B.M., Collin, F., Cope, L.M., Hobbs, B. Speed, T.P 2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31, e15.
21. Jurata, L.W., Gallagher, P., Lemire, A.L., Charles, V., Brockman, J.A., Illingworth, E.L. Altar, C.A 2006) Altered expression of hippocampal dentate granule neuron genes in a mouse model of human 22q11 deletion syndrome. Schizophr Res 88, 251 259.
22. Kendler, K.S., Thornton, L.M. Gardner, C.O 2001) Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression. Am J Psychiatry 158, 582 586.
23. Kessler, R.C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K.R., Rush, A.J., Walters, E.E. Wang, P.S 2003) The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289, 3095 3105.
24. Kohen, R., Kirov, S., Navaja, G.P., Happe, H.K., Hamblin, M.W., Snoddy, J.R., Neumaier, J.F. Petty, F 2005) Gene expression profiling in the hippocampus of learned helpless and nonhelpless rats. Pharmacogenomics J 5, 278 291.
25. Kosten, T.A., Galloway, M.P., Duman, R.S., Russell, D.S. D'Sa, C 2007) Repeated unpredictable stress and antidepressants differentially regulate expression of the Bcl-2 family of apoptotic genes in rat cortical, hippocampal, and limbic brain structures. Neuropsychopharmacology doi: 10.1038/sj.npp. 1301527.
26. Kroes, R.A., Panksepp, J., Burgdorf, J., Otto, N.J. Moskal, J.R 2006) Modeling depression: social dominance-submission gene expression patterns in rat neocortex. Neuroscience 137, 37 49.
27. Kuhn, H.G., Palmer, T.D. Fuchs, E 2001) Adult neurogenesis: a compensatory mechanism for neuronal damage. Eur Arch Psychiatry Clin Neurosci 251, 152 158.
28. Laifenfeld, D., Karry, R., Klein, E. Ben-Shachar, D 2005) Alterations in cell adhesion molecule L1 and functionally related genes in major depression: a postmortem study. Biol Psychiatry 57, 716 725.
29. Leitch, M.M., Ingram, C.D., Young, A.H., McQuade, R. Gartside, S.E 2003) Flattening the corticosterone rhythm attenuates 5-HT1A autoreceptor function in the rat: relevance for depression. Neuropsychopharmacology 28, 119 125.
30. Leith, N.J. Barrett, R.J 1980) Effects of chronic amphetamine or reserpine on self-stimulation responding: animal model of depression? Psychopharmacology (Berl) 72, 9 15.
31. Leonard, B.E 2007) Inflammation, depression and dementia: are they connected? Neurochem Res 32, 1749 1756.
32. Lucassen, P.J., Fuchs, E. Czeh, B 2004) Antidepressant treatment with tianeptine reduces apoptosis in the hippocampal dentate gyrus and temporal cortex. Biol Psychiatry 55, 789 796.
33. Maes, M 1999) Major depression and activation of the inflammatory response system. Adv Exp Med Biol 461, 25 46.
34. Magavi, S.S., Leavitt, B.R. Macklis, J.D 2000) Induction of neurogenesis in the neocortex of adult mice. Nature 405, 951 955.
35. Manji, H.K., Drevets, W.C. Charney, D.S 2001) The cellular neurobiology of depression. Nat Med 7, 541 547.
36. Mann, J.J., Stanley, M., McBride, P.A. McEwen, B.S 1986) Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 43, 954 959.
37. Murray, F., Smith, D.W. Hutson, P.H 2008) Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice. Eur J Pharmacol 583, 115 127.
38. Myint, A.M., Kim, Y.K., Verkerk, R., Scharpe, S., Steinbusch, H. Leonard, B 2007) Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord 98, 143 151.
39. Nakatani, N., Aburatani, H., Nishimura, K., Semba, J. Yoshikawa, T 2004) Comprehensive expression analysis of a rat depression model. Pharmacogenomics J 4, 114 126.
40. Nandam, L.S., Jhaveri, D. Bartlett, P 2007) 5-HT7, neurogenesis and antidepressants: a promising therapeutic axis for treating depression. Clin Exp Pharmacol Physiol 34, 546 551.
41. Nemeroff, C.B 1996) The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry 1, 336 342.
42. Nibuya, M., Morinobu, S. Duman, R.S 1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15, 7539 7547.
43. Owada, Y., Abdelwahab, S.A., Kitanaka, N., Sakagami, H., Takano, H., Sugitani, Y., Sugawara, M., Kawashima, H., Kiso, Y., Mobarakeh, J.I., Yanai, K., Kaneko, K., Sasaki, H., Kato, H., Saino-Saito, S., Matsumoto, N., Akaike, N., Noda, T. Kondo, H 2006) Altered emotional behavioral responses in mice lacking brain-type fatty acid-binding protein gene. Eur J Neurosci 24, 175 187.
44. Pandey, G.N., Dwivedi, Y., Rizavi, H.S., Ren, X., Pandey, S.C., Pesold, C., Roberts, R.C., Conley, R.R. Tamminga, C.A 2002) Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry 159, 419 429.
45. Peet, M. Stokes, C 2005) Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs 65, 1051 1059.
46. Raone, A., Cassanelli, A., Scheggi, S., Rauggi, R., Danielli, B. De Montis, M.G 2007) Hypothalamus-pituitary-adrenal modifications consequent to chronic stress exposure in an experimental model of depression in rats. Neuroscience 146, 1734 1742.
47. Sheline, Y.I 2003) Neuroimaging studies of mood disorder effects on the brain. Biol Psychiatry 54, 338 352.
48. Skynner, H.A., Amos, D.P., Murray, F., Salim, K., Knowles, M.R., Munoz-Sanjuan, I., Camargo, L.M., Bonnert, T.P. Guest, P.C 2006) Proteomic analysis identifies alterations in cellular morphology and cell death pathways in mouse brain after chronic corticosterone treatment. Brain Res 1102, 12 26.
49. Slotkin, T.A., Cousins, M.M., Tate, C.A. Seidler, F.J 2005) Serotonergic cell signaling in an animal model of aging and depression: olfactory bulbectomy elicits different adaptations in brain regions of young adult vs aging rats. Neuropsychopharmacology 30, 52 57.
50. Song, C. Leonard, B.E 2005) The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev 29, 627 647.
51. Sullivan, P.F., Neale, M.C. Kendler, K.S 2000) Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 157, 1552 1562.
52. Vengeliene, V., Leonardi-Essmann, F., Perreau-Lenz, S., Gebicke-Haerter, P., Drescher, K., Gross, G. Spanagel, R 2006) The dopamine D3 receptor plays an essential role in alcohol-seeking and relapse. FASEB J 20, 2223 2233.
53. Wang, D., Noda, Y., Tsunekawa, H., Zhou, Y., Miyazaki, M., Senzaki, K. Nabeshima, T 2007) Behavioural and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety. Behav Brain Res 178, 262 273.
54. Wrynn, A.S., Mac Sweeney, C.P., Franconi, F., Lemaire, L., Pouliquen, D., Herlidou, S., Leonard, B.E., Gandon, J. de Certaines, J.D 2000) An in-vivo magnetic resonance imaging study of the olfactory bulbectomized rat model of depression. Brain Res 879, 193 199.